Dr. Matthew A. Manning, MD

Dr. Manning practices at Piedmont Radiation Oncologists, PA in Charlotte, North Carolina.

Dr. Manning's NPI, 1316999857, was assigned on May 16, 2006. Dr. Manning graduated from VCU School of Medicine in 1996. Dr. Manning holds North Carolina license 200100410.

Dr. Manning's primary practice is Piedmont Radiation Oncologists, PA, at 200 Queens Rd, Charlotte, NC 28204 in Mecklenburg County. The practice phone is (336) 832-1100.

Dr. Manning's primary practice is Piedmont Radiation Oncologists, PA in Charlotte, North Carolina. Dr. Manning is also affiliated with Cone Health Moses Cone Hospital. The medical group on file is Piedmont Radiation Oncology at Cone Health Cancer Center. Dmand AI also links Dr. Manning to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manning practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Manning's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Manning is board certified in clinical informatics by the American Board of Preventive Medicine. Dmand AI has Dr. Manning's licenses on file in 2 states: North Carolina and Virginia.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, lung cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Manning treats.

CMS data shows 2,132 Medicare services from Dr. Manning across 17 procedure codes in 2024, for 210 Medicare patients. Medicare paid $158,290 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 210 Medicare patients who saw Dr. Manning in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have cancer, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manning's median patient age at 72, with 17% women.

In 2024, Dr. Manning wrote 137 Medicare Part D claims for 64 patients. 97% of them were for generic drugs. CMS names the drug for 85 of them, across 2 drugs with 11 or more claims each, at $592 in total drug cost. In 2023, CMS named 67 claims across 2 drugs.

Dr. Manning accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manning as offering telehealth.

Dmand AI links 19 papers to Dr. Manning, published from 2012 to 2022. 2019 was the busiest year, with 3. The most frequent topics are Healthcare Disparities, Lung Neoplasms and Black or African American. Dr. Manning has published most often in J Appl Clin Med Phys. Dr. Manning's most frequent co-authors are Stuart Heinrich Burri, MD, Roshan Sudhir Prabhu, MD and Jessica D. Arden, MD, PhD.

Dmand AI links Dr. Manning to 1 clinical trial. Conditions studied include Gliosarcoma and Glioblastoma.

CMS Open Payments shows 102 general payments to Dr. Manning from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Intuitive Surgical, Inc. paid the most, $30,672.

Dmand AI lists 10 awards for Dr. Manning, most recently CMS Stage 1 EHR in 2013.

Dr. Manning graduated from VCU School of Medicine in 1996. Dr. Manning is a member of American Brachytherapy Society (ABS) and ASTRO.

Dr. Manning is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.